glp-1 and thyroid medication Do Weight-Loss Shots Really Raise Cancer Risk? With the rapid expansion of GLP-1 medications for diabetes weight loss, public concern has grown regarding a possible link to thyroid cancer glp 1 drugs and hashimoto's

Description

Researchers conducted a prospective single-center cohort study of adults with a BMI of 27 kg/m2 or higher using liraglutide (Victoza/Saxenda, Novo Nordisk) or semaglutide (Ozempic/Wegovy, Novo Nordisk)

David Joffe, BSPharm, CDE Tina Burge, PharmD Candidate Florida A&M University Kiet Ngo, Pharm D Candidate Mercer University Abnormalities in incretin

Find out how now.

No afternoon crashes, curbed appetite, and increased energy

Development of a ligand-based proximity labeling strategy enables interrogation of the native cell membrane interactome for the GLP-1 receptor in two cell types, revealing new regulators of receptor-mediated signaling and cell responses.